Bactiguard completes a directed new share issue to AMF, raising approximately SEK 228 million
The board of directors of Bactiguard Holding AB (publ) ("Bactiguard") has resolved on a directed new share issue of1,500,000 B shares at a price of SEK 152 per share, corresponding to approximately SEK 228 million. STOCKHOLM, Sept. 22, 2021 /PRNewswire/ -- The Board of Directors of Bactiguard ha...
Bactiguard maintains clear growth strategy and updates financial targets
STOCKHOLM, Nov. 5, 2020 /PRNewswire/ -- Bactiguard presents updated financial targets for 2025 in connection with the company's financial report for the third quarter of 2020. Bactiguard's growth strategy for the coming five-year period up to 2025 is based on a continued roll-out of Bactiguard's...
Bactiguard Donates Infection Prevention to China
STOCKHOLM, March 4, 2020 /PRNewswire/ -- In the fight against the Corona virus, Bactiguard donates products for infection prevention to Chinese hospitals, at a market value of over2 million SEK. "To help fight the new corona virus (covid-19) and protect the most severely ill patients, we will do...
Bactiguard Makes its First Acquisition by Acquiring Vigilenz
STOCKHOLM, Feb. 4, 2020 /PRNewswire/ -- Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz) in Malaysia. The acquisition strengthens Bactiguard's position in infection control and wound management, a...
New Major Order From China
STOCKHOLM, Dec. 27, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate revenues in the fourth quarter of approximatelySEK 16.5 million. "This is the second order from Well Lead outside the initial...
Bactiguard Holding AB (publ): Interim Report for Q3 2019
STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of Bactigua...
New Major Order From China
STOCKHOLM, Sept. 30, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate revenues in the third quarter of approximatelySEK 4,8 million. "The order we have just received from Well Lead is the first ...
Bactiguard Signs Global License Agreement With Zimmer Biomet
STOCKHOLM, Sept. 27, 2019 /PRNewswire/ -- Bactiguard has entered into an exclusive, global license agreement for orthopedic trauma implants with Zimmer Biomet. The agreement includes an upfront license fee ofUSD 3 million payable at signing, additional contingent payments ofUSD 2 million, based o...
Bactiguard Recruits Experienced Chief Medical and Technology Officer
STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Stefan Grass with extensive clinical experience as a physician and researcher, combined with senior positions in the pharmaceutical industry, has been recruited to a newly established, global role as Chief Medical and Technology Officer. He will assume his...
Bactiguard Holding AB (publ): Interim Report for Q2 2019
STOCKHOLM, Aug. 8, 2019 /PRNewswire/ -- The second quarter of 2019 was eventful. We increased our market coverage, secured funding for a very interesting research and development project, broadened the clinical evidence and strengthened executive management. Revenues and earnings were weaker than...
